Victoza Side Effects & What You Should Know

Victoza side effects can be life-threatening. The once-a-day injection for type 2 diabetes puts patients at a higher risk for developing pancreatic cancer and serious allergic reactions. If you or a loved one were diagnosed with pancreatic cancer believed to be caused by Victoza, contact attorneys at Watts Guerra.

Among the serious Victoza side effects are:

  • Pancreatic Cancer
  • Severe Allergic Reactions

Signs & Symptoms of Pancreatitis

Abdominal pain is a common sign of pancreatitis. The pain may initially be mild and then increase in intensity or you may suddenly develop severe pain in your upper abdomen that radiates to your back. The pain may begin or become worse after eating and may feel worse when laying flat on your back. The pain could last for a few days. Your abdomen may also be swollen and tender.

You may experience nausea. If vomiting occurs, it likely will not relieve your sick feeling. You may also experience fever, chills, and/or a rapid heartbeat.

Signs & Symptoms of Pancreatic Cancer

Pancreatic Cancer is a silent disease, meaning the cancer can progress without early warning signs. The symptoms of pancreatic cancer are also similar to pancreatitis: pain in the upper abdomen, nausea and vomiting. You may experience weight loss and feel weak. Your skin and eyes may appear yellow, your urine look darker and your stools appear pale or gray.

Minor Side Effects of Victoza

Minor side effects of Victoza use may include constipation, diarrhea, decreased appetite, headache, dizziness, nausea, redness/swelling at the injection site, mild back pain, mild stomach pain, sinus problems, sore throat and mild vomiting.

What is Victoza?

The diabetes drug Victoza (Liraglutide) is in a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. It is used along with diet and exercise to help control blood sugar levels in adults with non-insulin dependent (type 2) diabetes. Type 2 (adult-onset diabetes), the most common type, accounts for about 90-95% of diabetes cases. An estimated 26 million Americans are diagnosed with diabetes and another 79 million are pre-diabetic.

Denmark’s Novo Nordisk, the world’s largest insulin producer, is the maker of Victoza.

FDA Approval of Victoza Followed by Safety Warnings

On January 25, 2010 the U.S. Food and Drug Administration approved Victoza to treat type 2 diabetes in some adults. The approval required a Risk Evaluation and Mitigation Strategy because studies showed Victoza caused thyroid cancer in rats and mice and patients using the drug are at a higher risk for developing acute pancreatitis.

In June 2011 the FDA issued a safety warning about the potential risks for thyroid cancer and acute pancreatitis in patients using Victoza. Due to post marketing reports, the FDA required Novo Nordisk to put a warning on Victoza about acute and chronic renal failure, and later required another warning about serious allergic reactions.

Petition for Recall of Victoza

On April 19, 2012 the consumer advocacy group Public Citizen filed a petition with the FDA calling for immediate removal of Victoza from the market because the higher risk of thyroid cancer, pancreatitis, kidney failure and serious allergic reactions outweigh documented clinical benefits of using the drug, especially considering there are safer drugs on the market. According to the petition, FDA clinical safety reviewer Dr. Karen Mahoney was against FDA approval of Victoza due to serious risk concerns. After reviewing the FDA’s adverse event database, the advocacy group determined that potentially 2,000 or more patients suffered painful and serious side effects as a result of taking Victoza.

About 150,000 prescriptions for Victoza are filled each month, and Norvo Nordisk’s multi-billion dollar revenues jumped in 2011, thanks to Victoza. The new drug is now being considered as a treatment for obesity and, according to new reports, has a 43 percent chance for approval in the U.S.

Victoza Lawsuits

The defective drug lawyers at Watts Guerra agree that the FDA should immediately remove Victoza from the market. Our attorneys, including some of the country’s most successful pharmaceutical lawyers, can help those diagnosed with pancreatic cancer as a result of taking the diabetes drug pursue compensation under the law.

If you believe your pancreatic cancer or a loved one’s death was the result of taking Victoza, contact us now for a free case evaluation.

Disclaimer: The images on this page of the Victoza packaging, product, and/or logo are for informational purposes; this website is neither affiliated with nor sponsored, endorsed, or approved by Norvo Nordisk.

Free Case Evaluation

Disclaimer | Privacy Policy

Bookmark and Share

Mikal C. Watts

Mikal C. Watts Mikal C. Watts is one of the most successful pharmaceutical lawyers in the country. He has handled many mass torts, including Ortho-Evra, Vioxx, Fen Phen, Rezulin, Zyprexa, and Sulzer hip implants. Mr. Watts leads a team of successful trial lawyers who handle pharmaceutical product liability cases across the country.

Ryan L. Thompson

Ryan L. Thompson Ryan L. Thompson leads the firm's pharmaceutical and medical device litigation department. He serves as the firm's lead counsel for Actos, NuvaRing, DePuy Hips, Transvaginal Mesh, and other torts. Additionally, Ryan was appointed to serve as Co-Lead counsel nationally in the Incretin-Based Therapies MDL by US District Judge Anthony Battaglia for plaintiff's claiming injuries related to Byetta, Januvia, Janumet, and Victoza.
Contact us using our online form, or call us toll-free at 1(800)796-9605.